Table 3.
MIC Value of FSE-Derived ZnO NPs Against Microbial Pathogens
| Microbial Pathogens | MIC Value (μg/mL) | |
|---|---|---|
| ZnO-NPs | Amp# (10 mcg) | |
| Bacterial pathogens | ||
| E. coli ESBL ATCC 9637 | >256.00* | 64.00 |
| E. faecium VRE | 16.00 | 8.00 |
| S. aureus ATCC 43300 | 32.00 | 16.00 |
| B. subtilis WS15 | >256.00* | 16.00 |
| P. aeroginosa ATCC 27584 | 64.00 | 16.00 |
| S. typhimurium ATCC 14028 | 32.00 | 16.00 |
| K. pneumoniae ATCC 13883 | >256.00* | 32.00 |
| Fungal pathogens | Ns$ (50 mcg) | |
| C. albicans ATCC 8436 | 16.00 | 8.00 |
| C. parapsilosis ATCC 22019 | 128.00 | 16.00 |
| Cryptococcus sp. | 32.00 | 16.00 |
Notes: #Amp, Ampicillin; $Ns, Nystatin; *Requires high volume of FSE-derived ZnO NPs required to inhibits the growth of a specific strains.